Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Class 'A' Ordinary Shares
-
Shares outstanding
-
385,837,333
-
Total 13F shares
-
5,935,793
-
Share change
-
-363,657
-
Total reported value
-
$22,614,000
-
Put/Call ratio
-
38%
-
Price per share
-
$3.81
-
Number of holders
-
22
-
Value change
-
-$313,125
-
Number of buys
-
12
-
Number of sells
-
11
Institutional Holders of Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) as of Q4 2020
As of 31 Dec 2020,
Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) was held by
22 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,935,793 shares.
The largest 10 holders included
RENAISSANCE TECHNOLOGIES LLC, HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC, STONEHILL CAPITAL MANAGEMENT LLC, ACADIAN ASSET MANAGEMENT LLC, MORGAN STANLEY, TWO SIGMA INVESTMENTS, LP, MILLENNIUM MANAGEMENT LLC, Navellier & Associates Inc, SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC, and WEALTHSOURCE PARTNERS, LLC.
This page lists
22
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.